Monogenic autoinflammatory disorders: conceptual overview, phenotype, and clinical approach

PA Nigrovic, PY Lee, HM Hoffman - Journal of Allergy and Clinical …, 2020 - Elsevier
Autoinflammatory diseases are conditions in which pathogenic inflammation arises primarily
through antigen-independent hyperactivation of immune pathways. First recognized just …

Molecular mechanisms of phenotypic variability in monogenic autoinflammatory diseases

I Aksentijevich, O Schnappauf - Nature Reviews Rheumatology, 2021 - nature.com
Monogenic autoinflammatory diseases are a group of rheumatologic disorders caused by
dysregulation in the innate immune system. The molecular mechanisms of these disorders …

Genotype and functional correlates of disease phenotype in deficiency of adenosine deaminase 2 (DADA2)

PY Lee, ES Kellner, Y Huang, E Furutani… - Journal of allergy and …, 2020 - Elsevier
Background Deficiency of adenosine deaminase 2 (DADA2) is a syndrome with pleiotropic
manifestations including vasculitis and hematologic compromise. A systematic definition of …

[HTML][HTML] The spectrum of the deficiency of adenosine deaminase 2: an observational analysis of a 60 patient cohort

KS Barron, I Aksentijevich, NT Deuitch… - Frontiers in …, 2022 - frontiersin.org
The deficiency of adenosine deaminase 2 (DADA2) is an autosomal recessively inherited
disease that has undergone extensive phenotypic expansion since being first described in …

Expanding spectrum of DADA2: a review of phenotypes, genetics, pathogenesis and treatment

B Pinto, P Deo, S Sharma, A Syal, A Sharma - Clinical Rheumatology, 2021 - Springer
Deficiency of adenosine deaminase 2 (DADA2) is a monogenic disease caused by biallelic
mutations in ADA2 gene (previously CECR1). The aim of this review was to describe the …

Evaluation and management of deficiency of adenosine deaminase 2: an international consensus statement

PY Lee, BA Davidson, RS Abraham, B Alter… - JAMA network …, 2023 - jamanetwork.com
Importance Deficiency of adenosine deaminase 2 (DADA2) is a recessively inherited
disease characterized by systemic vasculitis, early-onset stroke, bone marrow failure, and/or …

Deficiency of adenosine deaminase 2 in adults and children: experience from India

A Sharma, G Naidu, V Sharma, S Jha… - Arthritis & …, 2021 - Wiley Online Library
Objective Deficiency of adenosine deaminase 2 (DADA2) is a potentially fatal monogenic
syndrome characterized by variable manifestations of systemic vasculitis, bone marrow …

Mechanisms of vascular inflammation in deficiency of adenosine deaminase 2 (DADA2)

PY Lee, I Aksentijevich, Q Zhou - Seminars in Immunopathology, 2022 - Springer
Deficiency of adenosine deaminase 2 (DADA2) was first described as a monogenic form of
systemic vasculitis that closely resembles polyarteritis nodosa (PAN). The phenotypic …

[HTML][HTML] How to build a fire: the genetics of autoinflammatory diseases

J Zhang, PY Lee, I Aksentijevich… - Annual Review of …, 2023 - annualreviews.org
Systemic autoinflammatory diseases (SAIDs) are a heterogeneous group of disorders
caused by excess activation of the innate immune system in an antigen-independent …

Anti-tumour necrosis factor treatment for the prevention of ischaemic events in patients with deficiency of adenosine deaminase 2 (DADA2)

S Cooray, E Omyinmi, Y Hong, C Papadopoulou… - …, 2021 - academic.oup.com
Objective To evaluate the impact of anti-Tumour Necrosis Factor-α (anti-TNF) treatment on
the occurrence of vasculitic ischaemic events in patients with deficiency of adenosine …